2BB score and signals
Cytek Biosciences, Inc.’s current 2BB score is 58 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|---|---|
| Activity | 64 | High |
| Momentum | 52 | Stable |
| Financial strength | 32 | Weak |
| Quality | 100 | Very Strong |
| Risk | 40 | Moderate |
Cytek Biosciences, Inc. (CTKB) Stock Score & Signals
Cytek Biosciences, Inc. (CTKB) trades on NASDAQ. It operates in the Health Care sector, Medical Devices industry. Its current 2BB score is 58 out of 100.
Company facts
| Founded | 1992 |
| Employees | 682 |
| 52-week range | $3.28 – $6.18 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|---|---|---|---|
| 2027-02-24 | — | -0.0255 | — | $64.72M |
| 2026-11-03 | — | -0.0714 | — | $53.86M |
| 2026-08-05 | — | -0.0867 | — | $49.58M |
| 2026-05-07 | -0.15 | -0.0969 | $44.13M | $45.21M |